Summary of Purpose
The WAVECREST PMCF Study is a prospective, non-randomized, multicenter study to confirm safety and performance of the Coherex WaveCrest Left Atrial Appendage (LAA) Occlusion System in the current medical practice setting in patients with non-valvular atrial fibrillation who are at increased risk for stroke. Up to 65 subjects may be enrolled at up to 15 study sites in Europe. Patients will be followed through 45...Read More →
The following dates are available for this trial. Trial information last updated on 6 February 2018.
|29 May 2017||16 Jun 2017||13 Jul 2018||13 Aug 2018||1 Feb 2018||Unavailable|
|Start Date||First Received||1st Completion||Completion||Verification||Results|
- Coherex Medical Lead